Texas Instruments Edges Slightly Upward, Just Barely Topping Estimates

Michael Teague |

Texas Instruments Edges Slightly Upward, Just Barely Topping EstimatesTexas Instruments (TXN) reported earnings on Monday that indicated that the semiconductor company brought in a net income of $362 million, or $0.32 per share on revenue of $2.89 billion, squeezing in just ahead of expectations of $0.31 per share on revenue of $2.85 billion.

The earnings figures for the first quarter also represent a 37 percent increase that can be attributed to lower costs, even while revenue is down 7.6 percent.

The company saved money with the cost of making chips down 5 percent, while spending on research and development was down 18 percent to $419 million. Acquisitions expenses were down by nearly half, to $86 million.



Furthermore, the company has begun turning away from mobile, as most of the producers of smartphones and tablets which it used to supply have transitioned to making these components themselves. The general situation has also led to layoffs in its wireless business.

The company reported losses in sales almost across the board, including in analog chips, down 2 percent, with other revenue down 24 percent. The only increase came in the form of revenue from embedded processing that was up 4 percent.

Texas Instruments has, in the meantime, emphasized different aspects of its business such as producing processors for cars, robotics, and health care in order to adapt to changing market conditions. The company forecasts earnings for the current quarters of $0.37 to $0.45 per share, and revenue of $2.93 billion to $3.17 billion, while estimates currently have these figures at $0.38 per share on revenue of $3.04 billion.

At the close of regular trading, the company’s shares were up 1.64 percent to $34.81, but got a slight bump of about half of a percent in late trading as well.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
TXN Texas Instruments Incorporated 74.75 0.87 1.18 6,661,449
SBAC SBA Communications Corporation 105.53 -0.23 -0.22 846,603

Comments

Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…

Knightscope

Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.